Recent Updates
Recently added Catalysts
RVTY

PerkinElmer Announces Financial Results for the Second Quarter of 2019 Revenue of $722.5 million; 3% Reported growth; Organic growth of 5% GAAP EPS from continuing operations of $0.62; Adjusted EPS of $1.00 GAAP operatin

Key Takeaway: PerkinElmer Announces Financial Results for the Second Quarter of 2019 Revenue of $722.5 million; 3% Reported growth; Organic growth of 5% GAAP EPS from continuing operations of $0.62; Adjusted EPS of $1.00 GAAP operating income margin from continuing operations of 12.7%; Adju

Full Press Release Details

PerkinElmer Announces Financial Results for the Second Quarter of 2019

Revenue of $722.5 million; 3% Reported growth; Organic growth of 5%
GAAP EPS from continuing operations of $0.62; Adjusted EPS of $1.00
GAAP operating income margin from continuing operations of 12.7%; Adjusted operating income margin from continuing operations of 20.2%. Strong operating margin improvement year-to-date.
Updating GAAP EPS guidance range to $2.61 to $2.66; Reiterating adjusted EPS guidance range of $4.02 to $4.07
WALTHAM, Mass.--(BUSINESS WIRE)--July 29, 2019--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the second quarter ended June 30, 2019.
The Company reported GAAP earnings per share from continuing operations of $0.62, as compared to GAAP earnings per share from continuing operations of $0.58 in the second quarter of 2018. GAAP revenue for the quarter was $722.5 million, as
compared to $703.4 million in the second quarter of 2018. GAAP operating income from continuing operations for the quarter was $91.7 million, as compared to $88.1 million in the second quarter of 2018. GAAP operating profit margin was 12.7% as
a percentage of revenue, as compared to 12.5% in the second quarter of 2018.
Adjusted earnings per share from continuing operations for the quarter was $1.00, as compared to $0.91 in the second quarter of 2018. Adjusted revenue for the quarter was $722.7 million, as compared to $703.6 million in the second quarter of
2018. Adjusted operating income from continuing operations for the quarter was $146.0 million, as compared to $138.3 million for the same period a year ago. Adjusted operating profit margin was 20.2% as a percentage of adjusted revenues, as
compared to 19.7% in the second quarter of 2018.
Adjustments for the Company's non-GAAP financial measures have been noted in the attached reconciliations.
"I am very pleased with our second quarter performance as we continued to make significant progress against our key long-term priorities while also generating mid-single digit organic revenue growth and double-digit adjusted EPS growth," said
Robert Friel, chairman and chief executive officer of PerkinElmer. "The actions we are taking not only position us for a strong finish to 2019 but further evolve the company to deliver higher growth, greater resiliency and increased
Financial Overview by Reporting Segment for the Second Quarter of 2019
Discovery & Analytical Solutions
Revenue was $434.0 million, as compared to $430.6 million for the second quarter of 2018. Reported revenue increased 1% and organic revenue increased 2%.
Operating income from continuing operations was $57.7 million, as compared to $64.7 million for the comparable prior period.
Adjusted operating income was $81.5 million, as compared to $76.4 million in the second quarter of 2018.
Revenue was $288.6 million, as compared to $272.7 million for the second quarter of 2018. Reported revenue increased 6% and organic revenue increased 9%.
Operating income from continuing operations was $49.3 million, as compared to $38.8 million for the comparable prior period.
Adjusted operating income was $79.7 million, as compared to $77.2 million in the second quarter of 2018.
Full Year 2019 Guidance
For the full year 2019, the Company now forecasts GAAP earnings per share from continuing operations in a range of $2.61 to $2.66 and, on a non-GAAP basis, which is expected to include the adjustments noted in the attached reconciliations,
adjusted earnings per share of $4.02 to $4.07.
Conference Call Information
The Company will discuss its second quarter 2019 results and its outlook for business trends in a conference call on July 29, 2019 at 5:00 p.m. Eastern Time. To access the call, please dial (720) 405-2250 prior to the scheduled conference
call time and provide the access code 2774907.
A live audio webcast of the call will be available on the Investors section of the Company's website, www.perkinelmer.com. Please go to the site at least 15 minutes prior to the call in order to register, download, and install any necessary
software. An archived version of the webcast will be posted on the Company's website for a two-week period beginning approximately two hours after the call.
Use of Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings announcement also contains non-GAAP financial measures. The reasons that we use these measures, a reconciliation of
these measures to the most directly comparable GAAP measures, and other information relating to these measures are included below following our GAAP financial statements.
Factors Affecting Future Performance
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share,
cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities, acquisitions and divestitures. Words such as "believes," "intends,"
"anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and
expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in
any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) fluctuations in the global economic and political environments; (3) our failure
to introduce new products in a timely manner; (4) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable, or
successfully divest businesses; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results
and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply
of raw materials and supplies; (11) the manufacture and sale of products exposing us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to
comply with healthcare industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) significant disruption in our information technology systems, or
cybercrime; (18) our ability to obtain future financing; (19) restrictions in our credit agreements; (20) the United Kingdom's intention to withdraw from the European Union; (21) our ability to realize the full value of our intangible assets;
(22) significant fluctuations in our stock price; (23) reduction or elimination of dividends on our common stock; and (24) other factors which we describe under the caption "Risk Factors" in our most recent quarterly report on Form 10-Q and in
our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.8 billion in 2018, has about 13,000 employees serving customers in more than 180 countries, and is a component
of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
PerkinElmer, Inc. and Subsidiaries
CONDENSED CONSOLIDATED INCOME STATEMENTS
Three Months Ended Six Months Ended
(In thousands, except per share data) June 30, 2019 July 1, 2018 June 30, 2019 July 1, 2018
Revenue $ 722,517 $ 703,362 $ 1,371,254 $ 1,347,334
Cost of revenue 374,724 363,222 715,655 714,972
Selling, general and administrative expenses 201,553 204,880 400,410 404,605
Research and development expenses 48,344 47,196 96,324 93,180
Restructuring and contract termination charges, net 6,161 - 13,800 6,578
Operating income from continuing operations 91,735 88,064 145,065 127,999
Interest income (350 ) (173 ) (633 ) (438 )
Interest expense 17,207 16,411 33,057 34,061
Loss on disposition of businesses and assets, net 336 - 2,469 -
Other expense (income), net 2,715 118 1,580 (5,837 )
Income from continuing operations, before income taxes 71,827 71,708 108,592 100,213
Provision for income taxes 2,686 7,035 3,998 9,505
Income from continuing operations 69,141 64,673 104,594 90,708
Loss on disposition of discontinued operations, before income taxes - (551 ) - (551 )
Provision for income taxes on discontinued operations and dispositions 54 59 95 70
Loss from discontinued operations and dispositions (54 ) (610 ) (95 ) (621 )
Net income $ 69,087 $ 64,063 $ 104,499 $ 90,087
Diluted earnings per share:
Income from continuing operations $ 0.62 $ 0.58 $ 0.94 $ 0.81
Loss from discontinued operations and dispositions (0.00 ) (0.01 ) (0.00 ) (0.01 )
Net income $ 0.62 $ 0.57 $ 0.94 $ 0.81
Weighted average diluted shares of common stock outstanding 111,528 111,452 111,411 111,391
ABOVE PREPARED IN ACCORDANCE WITH GAAP
Additional Supplemental Information (1) :
(per share, continuing operations)
GAAP EPS from continuing operations 0.62 0.58 0.94 0.81
Amortization of intangible assets 0.37 0.29 0.72 0.59
Purchase accounting adjustments 0.05 0.14 0.08 0.23
Significant litigation matter 0.00 (0.00 ) 0.01 0.04
Acquisition and divestiture-related costs 0.03 0.02 0.05 0.03
Disposition of businesses and assets, net 0.00 - 0.02 -
Restructuring and contract termination charges, net 0.06 - 0.12 0.06
Tax on above items (0.13 ) (0.12 ) (0.25 ) (0.24 )
Impact of tax act - - - 0.01
Adjusted EPS 1.00 0.91 1.69 1.54
(1) amounts may not sum due to rounding
PerkinElmer, Inc. and Subsidiaries
REVENUE AND OPERATING INCOME (LOSS)
Three Months Ended Six Months Ended
(In thousands, except percentages) June 30, 2019 July 1, 2018 June 30, 2019 July 1, 2018
DAS Reported revenue $ 433,967 $ 430,628 $ 822,800 $ 827,153
Reported operating income from continued operations 57,689 64,665 94,616 100,862
OP% 13.3 % 15.0 % 11.5 % 12.2 %
Amortization of intangible assets 13,113 11,472 23,382 23,183
Purchase accounting adjustments 5,014 15 5,051 30
Acquisition and divestiture-related costs 416 33 959 71
Significant litigation matter 439 232 815 4,417
Restructuring and contract termination charges, net 4,820 - 11,000 5,676
Adjusted operating income 81,491 76,417 135,823 134,239
Adjusted OP% 18.8 % 17.7 % 16.5 % 16.2 %
Diagnostics Reported revenue 288,550 272,734 548,454 520,181
Purchase accounting adjustments 192 188 384 375
Adjusted revenue 288,742 272,922 548,838 520,556
Reported operating income from continued operations 49,255 38,780 80,741 57,174
OP% 17.1 % 14.2 % 14.7 % 11.0 %
Amortization of intangible assets 28,089 21,045 56,547 42,234
Purchase accounting adjustments 516 16,103 4,087 25,631
Acquisition and divestiture-related costs 478 1,616 1,485 4,151
Significant litigation matter - (322 ) - (172 )
Restructuring and contract termination charges, net 1,341 - 2,800 902
Adjusted operating income 79,679 77,222 145,660 129,920
Adjusted OP% 27.6 % 28.3 % 26.5 % 25.0 %
Corporate Reported operating loss (15,209 ) (15,381 ) (30,292 ) (30,037 )
Continuing Operations Reported revenue $ 722,517 $ 703,362 $ 1,371,254 $ 1,347,334
Purchase accounting adjustments 192 188 384 375
Adjusted revenue 722,709 703,550 1,371,638 1,347,709
Reported operating income from continued operations 91,735 88,064 145,065 127,999
OP% 12.7 % 12.5 % 10.6 % 9.5 %
Amortization of intangible assets 41,202 32,517 79,929 65,417
Purchase accounting adjustments 5,530 16,118 9,138 25,661
Acquisition and divestiture-related costs 894 1,649 2,444 4,222
Significant litigation matter 439 (90 ) 815 4,245
Restructuring and contract termination charges, net 6,161 - 13,800 6,578
Adjusted operating income $ 145,961 $ 138,258 $ 251,191 $ 234,122
Adjusted OP% 20.2 % 19.7 % 18.3 % 17.4 %
REPORTED REVENUE AND REPORTED OPERATING INCOME (LOSS) PREPARED IN ACCORDANCE WITH GAAP
PerkinElmer, Inc. and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands) June 30, 2019 December 30, 2018
Current assets:
Cash and cash equivalents $ 150,016 $ 163,111
Accounts receivable, net 654,454 632,669
Inventories, net 414,330 338,347
Other current assets 118,961 100,507
Total current assets 1,337,761 1,234,634
Property, plant and equipment:
At cost 670,821 680,183
Accumulated depreciation (368,101 ) (361,593 )
Property, plant and equipment, net 302,720 318,590
Operating lease right-of-use assets 187,934 -
Intangible assets, net 1,282,440 1,199,667
Goodwill 3,042,049 2,952,608
Other assets, net 246,168 270,023
Total assets $ 6,399,072 $ 5,975,522
Current liabilities:
Current portion of long-term debt $ 38,043 $ 14,856
Accounts payable 188,051 220,949
Short-term accrued restructuring and contract termination charges 10,987 4,834
Accrued expenses and other current liabilities 497,426 528,827
Current liabilities of discontinued operations 2,130 2,165
Total current liabilities 736,637 771,631
Long-term debt 2,074,628 1,876,624
Long-term liabilities 716,929 742,312
Operating lease liabilities 164,011 -
Total liabilities 3,692,205 3,390,567
Total stockholders' equity 2,706,867 2,584,955
Total liabilities and stockholders' equity $ 6,399,072 $ 5,975,522
PREPARED IN ACCORDANCE WITH GAAP
PerkinElmer, Inc. and Subsidiaries
CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended Six Months Ended
June 30, 2019 July 1, 2018 June 30, 2019 July 1, 2018
(In thousands) (In thousands)
Operating activities:
Net income $ 69,087 $ 64,063 $ 104,499 $ 90,087
Loss from discontinued operations and dispositions, net of income taxes 54 610 95 621
Income from continuing operations 69,141 64,673 104,594 90,708
Adjustments to reconcile income from continuing operations
to net cash provided by continuing operations:
Stock-based compensation 6,703 6,816 12,801 12,148
Restructuring and contract termination charges, net 6,161 - 13,800 6,578
Depreciation and amortization 53,324 43,772 103,793 88,225
Change in fair value of contingent consideration 59 6,948 3,161 7,065
Amortization of deferred debt financing costs and accretion of discounts 929 904 1,790 1,519
Loss on disposition of businesses and assets, net 336 - 2,469 -
Amortization of acquired inventory revaluation 5,282 8,952 5,565 18,160
Changes in assets and liabilities which provided (used) cash, excluding
effects from companies acquired:
Accounts receivable, net (17,468 ) (8,488 ) (9,604 ) (18,768 )
Inventories (12,009 ) (17,965 ) (50,450 ) (42,993 )
Accounts payable (38,500 ) (14,358 ) (39,951 ) (24,384 )
Accrued expenses and other (27,100 ) (18,268 ) (106,425 ) (79,831 )
Net cash provided by operating activities of continuing operations 46,858 72,986 41,543 58,427
Net cash used in operating activities of discontinued operations - - - -
Net cash provided by operating activities 46,858 72,986 41,543 58,427
Investing activities:
Capital expenditures (16,586 ) (16,956 ) (36,461 ) (39,608 )
Purchases of investments (348 ) - (868 ) -
Purchases of licenses - - (5,000 ) -
Proceeds from surrender of life insurance policies - - - 72
Proceeds from disposition of businesses and assets - 173 550 173
Payment of acquisitions, net of cash and cash equivalents acquired (240,354 ) (39,470 ) (244,738 ) (40,557 )
Net cash used in investing activities of continuing operations (257,288 ) (56,253 ) (286,517 ) (79,920 )
Net cash provided by investing activities of discontinued operations - - - -
Net cash used in investing activities (257,288 ) (56,253 ) (286,517 ) (79,920 )
Financing Activities:
Payments on borrowings (426,000 ) (520,000 ) (578,000 ) (667,000 )
Proceeds from borrowings 670,550 138,000 849,550 342,000
Proceeds from sale of senior debt - 369,340 - 369,340
Payments of debt issuance costs (93 ) (2,634 ) (181 ) (2,634 )
Settlement of cash flow hedges 16 3,458 (1,659 ) (32,711 )
Net payments on other credit facilities (6,330 ) (7,147 ) (9,806 ) (10,154 )
Payments for acquisition-related contingent consideration (11,600 ) - (23,700 ) -
Proceeds from issuance of common stock under stock plans 7,944 881 16,554 8,348
Purchases of common stock (764 ) (95 ) (6,057 ) (4,649 )
Dividends paid (7,764 ) (7,744 ) (15,507 ) (15,471 )
Net cash provided by (used in) financing activities of continuing operations 225,959 (25,941 ) 231,194 (12,931 )
Net cash used in financing activities of discontinued operations - - - -
Net cash provided by (used in) financing activities 225,959 (25,941 ) 231,194 (12,931 )
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 235 (8,201 ) 685 (4,351 )
Net increase (decrease) in cash, cash equivalents, and restricted cash 15,764 (17,409 ) (13,095 ) (38,775 )
Cash, cash equivalents, and restricted cash at beginning of period 137,456 181,005 166,315 202,371
Cash, cash equivalents, and restricted cash at end of period $ 153,220 $ 163,596 $ 153,220 $ 163,596
Supplemental disclosure of cash flow information:
Reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total shown in the consolidated statements of cash flows:
Cash and cash equivalents 150,016 $ 163,392 150,016 $ 163,392
Restricted cash included in other current assets 3,204 204 3,204 204
Total cash, cash equivalents and restricted cash $ 153,220 $ 163,596 $ 153,220 $ 163,596
PREPARED IN ACCORDANCE WITH GAAP
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
(In millions, except per share data and percentages) PKI
Three Months Ended
June 30, 2019 July 1, 2018
Adjusted revenue:
Revenue $ 722.5 $ 703.4
Purchase accounting adjustments 0.2 0.2
Adjusted revenue $ 722.7 $ 703.6
Adjusted gross margin:
Gross margin $ 347.8 48.1 % $ 340.1 48.4 %
Amortization of intangible assets 15.6 2.2 % 11.6 1.6 %
Purchase accounting adjustments 5.5 0.8 % 9.2 1.3 %
Adjusted gross margin $ 368.9 51.0 % $ 360.9 51.3 %
Adjusted SG&A:
SG&A $ 201.6 27.9 % $ 204.9 29.1 %
Amortization of intangible assets (25.6 ) -3.5 % (20.9 ) -3.0 %
Purchase accounting adjustments (0.1 ) 0.0 % (7.0 ) -1.0 %
Acquisition and divestiture-related expenses (0.9 ) -0.1 % (1.6 ) -0.2 %
Significant litigation matter (0.4 ) -0.1 % 0.1 0.0 %
Adjusted SG&A $ 174.6 24.2 % $ 175.5 24.9 %
Adjusted R&D:
R&D $ 48.3 6.7 % $ 47.2 6.7 %
Amortization of intangible assets - 0.0 % (0.1 ) 0.0 %
Adjusted R&D $ 48.3 6.7 % $ 47.1 6.7 %
Adjusted operating income:
Operating income $ 91.7 12.7 % $ 88.1 12.5 %
Amortization of intangible assets 41.2 5.7 % 32.5 4.6 %
Purchase accounting adjustments 5.5 0.8 % 16.1 2.3 %
Acquisition and divestiture-related expenses 0.9 0.1 % 1.6 0.2 %
Significant litigation matter 0.4 0.1 % (0.1 ) 0.0 %
Restructuring and contract termination charges, net 6.2 0.9 % - 0.0 %
Adjusted operating income $ 146.0 20.2 % $ 138.3 19.7 %
PKI
Three Months Ended
June 30, 2019 July 1, 2018
Adjusted EPS:
GAAP EPS $ 0.62 $ 0.57
Discontinued operations, net of income taxes (0.00 ) (0.01 )
GAAP EPS from continuing operations 0.62 0.58
Amortization of intangible assets 0.37 0.29
Purchase accounting adjustments 0.05 0.14
Significant litigation matter 0.00 (0.00 )
Acquisition and divestiture-related expenses 0.03 0.02
Gain on disposition of businesses and assets, net 0.00 -
Restructuring and contract termination charges, net 0.06 -
Tax on above items (0.13 ) (0.12 )
Adjusted EPS $ 1.00 $ 0.91
DAS
Three Months Ended
June 30, 2019 July 1, 2018
Revenue $ 434.0 $ 430.6
Adjusted operating income:
Operating income $ 57.7 13.3 % $ 64.7 15.0 %
Amortization of intangible assets 13.1 3.0 % 11.5 2.7 %
Purchase accounting adjustments 5.0 1.2 % 0.0 0.0 %
Acquisition and divestiture-related expenses 0.4 0.1 % 0.0 0.0 %
Significant litigation matter 0.4 0.1 % 0.2 0.1 %
Restructuring and contract termination charges, net 4.8 1.1 % - 0.0 %
Adjusted operating income $ 81.5 18.8 % $ 76.4 17.7 %
Diagnostics
Three Months Ended
June 30, 2019 July 1, 2018
Adjusted revenue:
Revenue $ 288.6 $ 272.7
Purchase accounting adjustments 0.2 0.2
Adjusted revenue $ 288.7 $ 272.9
Adjusted operating income:
Operating income $ 49.3 17.1 % $ 38.8 14.2 %
Amortization of intangible assets 28.1 9.7 % 21.0 7.7 %
Purchase accounting adjustments 0.5 0.2 % 16.1 5.9 %
Acquisition and divestiture-related expenses 0.5 0.2 % 1.6 0.6 %
Significant litigation matter - 0.0 % (0.3 ) -0.1 %
Restructuring and contract termination charges, net 1.3 0.5 % - 0.0 %
Adjusted operating income $ 79.7 27.6 % $ 77.2 28.3 %
(1) amounts may not sum due to rounding
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
(In millions, except per share data and percentages) PKI
Six Months Ended
June 30, 2019 July 1, 2018
Adjusted revenue:
Revenue $ 1,371.3 $ 1,347.3
Purchase accounting adjustments 0.4 0.4
Adjusted revenue $ 1,371.6 $ 1,347.7
Adjusted gross margin:
Gross margin $ 655.6 47.8 % $ 632.4 46.9 %
Amortization of intangible assets 30.4 2.2 % 23.3 1.7 %
Purchase accounting adjustments 6.0 0.4 % 18.6 1.4 %
Adjusted gross margin $ 692.0 50.5 % $ 674.2 50.0 %
Adjusted SG&A:
SG&A $ 400.4 29.2 % $ 404.6 30.0 %
Amortization of intangible assets (49.5 ) -3.6 % (42.0 ) -3.1 %
Purchase accounting adjustments (3.2 ) -0.2 % (7.1 ) -0.5 %
Acquisition and divestiture-related expenses (2.4 ) -0.2 % (4.2 ) -0.3 %
Significant litigation matter (0.8 ) -0.1 % (4.2 ) -0.3 %
Adjusted SG&A $ 344.5 25.1 % $ 347.0 25.8 %
Adjusted R&D:
R&D $ 96.3 7.0 % $ 93.2 6.9 %
Amortization of intangible assets - 0.0 % (0.2 ) 0.0 %
Adjusted R&D $ 96.3 7.0 % $ 93.0 6.9 %
Adjusted operating income:
Operating income $ 145.1 10.6 % $ 128.0 9.5 %
Amortization of intangible assets 79.9 5.8 % 65.4 4.9 %
Purchase accounting adjustments 9.1 0.7 % 25.7 1.9 %
Acquisition and divestiture-related expenses 2.4 0.2 % 4.2 0.3 %
Significant litigation matter 0.8 0.1 % 4.2 0.3 %
Restructuring and contract termination charges, net 13.8 1.0 % 6.6 0.5 %
Adjusted operating income $ 251.2 18.3 % $ 234.1 17.4 %
PKI
Six Months Ended
June 30, 2019 July 1, 2018
Adjusted EPS:
GAAP EPS $ 0.94 $ 0.81
Discontinued operations (0.00 ) (0.01 )
GAAP EPS from continuing operations 0.94 0.81
Amortization of intangible assets 0.72 0.59
Purchase accounting adjustments 0.08 0.23
Significant litigation matter 0.01 0.04
Acquisition and divestiture-related expenses 0.05 0.03
Gain on disposition of businesses and assets, net 0.02 -
Restructuring and contract termination charges, net 0.12 0.06
Tax on above items (0.25 ) (0.24 )
Impact of tax act - 0.01
Adjusted EPS $ 1.69 $ 1.54
PKI
Twelve Months Ended
December 29, 2019
Adjusted EPS: Projected
GAAP EPS from continuing operations $2.61 - $2.66
Amortization of intangible assets 1.47
Purchase accounting adjustments 0.23
Significant litigation matter 0.01
Acquisition and divestiture-related expenses 0.05
Disposition of businesses and assets, net 0.02
Restructuring and contract termination charges, net 0.12
Tax on above items (0.49 )
Adjusted EPS $4.02 - $4.07
DAS
Six Months Ended
June 30, 2019 July 1, 2018
Revenue $ 822.8 $ 827.2
Adjusted operating income:
Operating income $ 94.6 11.5 % $ 100.9 12.2 %
Amortization of intangible assets 23.4 2.8 % 23.2 2.8 %
Purchase accounting adjustments 5.1 0.6 % 0.0 0.0 %
Acquisition and divestiture-related expenses 1.0 0.1 % 0.1 0.0 %
Significant litigation matter 0.8 0.1 % 4.4 0.5 %
Restructuring and contract termination charges, net 11.0 1.3 % 5.7 0.7 %
Adjusted operating income $ 135.8 16.5 % $ 134.2 16.2 %
Diagnostics
Six Months Ended
June 30, 2019 July 1, 2018
Adjusted revenue:
Revenue $ 548.5 $ 520.2
Purchase accounting adjustments 0.4 0.4
Adjusted revenue $ 548.8 $ 520.6
Adjusted operating income:
Operating income $ 80.7 14.7 % $ 57.2 11.0 %
Amortization of intangible assets 56.5 10.3 % 42.2 8.1 %
Purchase accounting adjustments 4.1 0.7 % 25.6 4.9 %
Acquisition and divestiture-related expenses 1.5 0.3 % 4.2 0.8 %
Significant litigation matter - 0.0 % (0.2 ) 0.0 %
Restructuring and contract termination charges, net 2.8 0.5 % 0.9 0.2 %
Adjusted operating income $ 145.7 26.5 % $ 129.9 25.0 %
(1) amounts may not sum due to rounding
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
PKI
Three Months Ended
June 30, 2019
Organic revenue growth:
Reported revenue growth 3%
Less: effect of foreign exchange rates -3%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses 1%
Organic revenue growth 5%
DAS
Three Months Ended
June 30, 2019
Organic revenue growth:
Reported revenue growth 1%
Less: effect of foreign exchange rates -3%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses 1%
Organic revenue growth 2%
Diagnostics
Three Months Ended
June 30, 2019
Organic revenue growth:
Reported revenue growth 6%
Less: effect of foreign exchange rates -3%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses 0%
Organic revenue growth 9%
(1) amounts may not sum due to rounding
Explanation of Non-GAAP Financial Measures
We report our financial results in accordance with GAAP. However, management believes that, in order to more fully understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain
non-cash, non-recurring or other items, which result from facts and circumstances that vary in frequency and impact on continuing operations. Accordingly, we present non-GAAP financial measures as a supplement to the financial measures we
present in accordance with GAAP. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by adjusting for certain non-cash expenses and other
items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management's ability to make useful forecasts. Management believes these
non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial
and operational performance and comparing this performance to our peers and competitors.
We use the term "adjusted revenue" to refer to GAAP revenue, including purchase accounting adjustments for revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules. We use the related term
"adjusted revenue growth" to refer to the measure of comparing current period adjusted revenue with the corresponding period of the prior year.
We use the term "organic revenue" to refer to GAAP revenue, excluding the effect of foreign currency changes and including acquisitions growth from the comparable prior period, and including purchase accounting adjustments for revenue from
contracts acquired in acquisitions that will not be fully recognized due to accounting rules. We also exclude the impact of sales from divested businesses by deducting the effects of divested business revenue from the current and prior periods.
We use the related term "organic revenue growth" to refer to the measure of comparing current period organic revenue with the corresponding period of the prior year.
We use the term "adjusted gross margin" to refer to GAAP gross margin, excluding amortization of intangible assets and inventory fair value adjustments related to business acquisitions, and including purchase accounting adjustments for
revenue from contracts acquired in acquisitions that will not be fully recognized due to business combination accounting rules. We use the related term "adjusted gross margin percentage" to refer to adjusted gross margin as a percentage of
We use the term "adjusted SG&A expense" to refer to GAAP SG&A expense, excluding amortization of intangible assets, purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters and
significant environmental charges. We use the related term "adjusted SG&A percentage" to refer to adjusted SG&A expense as a percentage of adjusted revenue.
We use the term "adjusted R&D expense" to refer to GAAP R&D expense, excluding amortization of intangible assets. We use the related term "adjusted R&D percentage" to refer to adjusted R&D expense as a percentage of adjusted
We use the term "adjusted operating income," to refer to GAAP operating income, including revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules, and excluding amortization of intangible
assets, other purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters, significant environmental charges, and restructuring and contract termination charges. We use the related terms
"adjusted operating profit percentage," "adjusted operating profit margin," or "adjusted operating margin" to refer to adjusted operating income as a percentage of adjusted revenue.
We use the term "adjusted earnings per share," or "adjusted EPS," to refer to GAAP earnings per share, including revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules, and excluding
discontinued operations, amortization of intangible assets, other purchase accounting adjustments, acquisition and divestiture-related expenses, significant litigation matters, significant environmental charges, disposition of businesses and
assets, net, and restructuring and contract termination charges. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate our non-GAAP measure. We also
adjust for any tax impact related to the above items, and exclude the impact of significant tax events.
Management includes or excludes the effect of each of the items identified below in the applicable non-GAAP financial measure referenced above for the reasons set forth below with respect to that item:
Amortization of intangible assets-purchased intangible assets are amortized over their estimated useful lives and generally cannot be changed or influenced by management after the acquisition. Accordingly, this item is not
considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
Revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules-accounting rules require us to account for the fair value of revenue from contracts assumed in connection with our
acquisitions. As a result, our GAAP results reflect the fair value of those revenues, which is not the same as the revenue that otherwise would have been recorded by the acquired entity. We include such revenue in our non-GAAP measures
because we believe the fair value of such revenue does not accurately reflect the performance of our ongoing operations for the period in which such revenue is recorded.
Other purchase accounting adjustments-accounting rules require us to adjust various balance sheet accounts, including inventory and deferred rent balances to fair value at the time of the acquisition. As a result, the
expenses for these items in our GAAP results are not the same as what would have been recorded by the acquired entity. Accounting rules also require us to estimate the fair value of contingent consideration at the time of the acquisition, and
any subsequent changes to the estimate or payment of the contingent consideration and purchase accounting adjustments are charged to expense or income. We exclude the impact of any changes to contingent consideration from our non-GAAP
measures because we believe these expenses or benefits do not accurately reflect the performance of our ongoing operations for the period in which such expenses or benefits are recorded.
Acquisition and divestiture-related expenses-we incur legal, due diligence, stay bonuses, interest expense, foreign exchange gains and losses, significant acquisition integration expenses and other costs related to
acquisitions and divestitures. We exclude these expenses from our non-GAAP measures because we believe they do not reflect the performance of our ongoing operations.
Restructuring and contract termination charges-restructuring and contract termination expenses consist of employee severance and other exit costs as well as the cost of terminating certain lease agreements or contracts.
Management does not believe such costs accurately reflect the performance of our ongoing operations for the period in which such costs are reported.
Adjustments for mark-to-market accounting on post-retirement benefits-we exclude adjustments for mark-to-market accounting on post-retirement benefits, and therefore only our projected costs are used to calculate our
non-GAAP measures. We exclude these adjustments because they do not represent what we believe our investors consider to be costs of producing our products, investments in technology and production, and costs to support our internal operating
Significant litigation matters-we incur expenses related to significant litigation matters. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which such
charges were incurred.
Significant environmental charges-we incur expenses related to significant environmental charges. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which
Last updated: Jul 29, 2019